The DOI matches its Crossref record; 101 of the 101 references it cites were found in a registry or an index.
Parkinson's disease.
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hughes, A. J., Daniel, S. E., Kilford, L., & Lees, A. J. (1992) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.55.3.181 · Cited by 10,378
Long-term suppression of tremor by chronic stimulation of the ventral intermediate thalamic nucleus
Benabid, A. L., Pollak, P., Hoffmann, D., Gervason, C., Hommel, M., Perret, J. E., de Rougemont, J., & Gao, D. M. (1991) · The Lancet · doi:10.1016/0140-6736(91)91175-t · Cited by 1,787
Effects of Tocopherol and Deprenyl on the Progression of Disability in Early Parkinson's Disease
(1993) · New England Journal of Medicine · doi:10.1056/nejm199301213280305 · Cited by 1,221
Grafts of Fetal Dopamine Neurons Survive and Improve Motor Function in Parkinson's Disease
Lindvall, O., Brundin, P., Widner, H., Rehncrona, S., Gustavii, B., Frackowiak, R., Leenders, K. L., Sawle, G., Rothwell, J. C., Marsden, C. D., et al. (1990) · Science · doi:10.1126/science.2105529 · Cited by 1,207
Self-citationLeksell's posteroventral pallidotomy in the treatment of Parkinson's disease
Laitinen, L. V., Bergenheim, A. T., & Hariz, M. I. (1992) · Journal of Neurosurgery · doi:10.3171/jns.1992.76.1.0053 · Cited by 1,081
A Clinicopathologic Study of 100 Cases of Parkinson's Disease
Hughes, A. J., Daniel, S. E., Blankson, S., & Lees, A. J. (1993) · Archives of Neurology · doi:10.1001/archneur.1993.00540020018011 · Cited by 956
Effect of Deprenyl on the Progression of Disability in Early Parkinson's Disease
The Parkinson Study Group* (1989) · New England Journal of Medicine · doi:10.1056/nejm198911163212004 · Cited by 917
‘Frontal' cognitive function in patients with Parkinson's disease ‘on' and ‘off' levodopa
GOTHAM, A. M., BROWN, R. G., & MARSDEN, C. D. (1988) · Brain · doi:10.1093/brain/111.2.299 · Cited by 835
Self-citationCOGNITIVE DEFICITS IN THE EARLY STAGES OF PARKINSON'S DISEASE
LEES, A. J., & SMITH, E. (1983) · Brain · doi:10.1093/brain/106.2.257 · Cited by 790
Freed, C. R., Breeze, R. E., Rosenberg, N. L., Schneck, S. A., Kriek, E., Qi, J.-X., Lone, T., Zhang, Y.-B., Snyder, J. A., Wells, T. H., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211263272202 · Cited by 739
"ON-OFF" EFFECTS IN PATIENTS WITH PARKINSON'S DISEASE ON CHRONIC LEVODOPA THERAPY
Marsden, C. D., & Parkes, J. D. (1976) · The Lancet · doi:10.1016/s0140-6736(76)91416-1 · Cited by 661
Self-citationAccuracy of Clinical Diagnosis in Parkinsonism — A Prospective Study
Rajput, A. H., Rozdilsky, B., & Rajput, A. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100031814 · Cited by 596
SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASE
Marsden, C. D., & Parkes, J. D. (1977) · The Lancet · doi:10.1016/s0140-6736(77)91146-1 · Cited by 587
Self-citationSenile dementia of Lewy body type
Perry, R. H., Irving, D., Blessed, G., Fairbairn, A., & Perry, E. K. (1990) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(90)90236-g · Cited by 571
Spencer, D. D., Robbins, R. J., Naftolin, F., Marek, K. L., Vollmer, T., Leranth, C., Roth, R. H., Price, L. H., Gjedde, A., Bunney, B. S., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211263272201 · Cited by 501
Widner, H., Tetrud, J., Rehncrona, S., Snow, B., Brundin, P., Gustavii, B., Björklund, A., Lindvall, O., & Langston, J. W. (1992) · New England Journal of Medicine · doi:10.1056/nejm199211263272203 · Cited by 488
Young onset Parkinson's disease
Quinn, N., Critchley, P., & Marsden, C. D. (1987) · Movement Disorders · doi:10.1002/mds.870020201 · Cited by 443
Self-citationOperational criteria for senile dementia of Lewy body type (SDLT)
McKeith, I. G., Perry, R. H., Fairbairn, A. F., Jabeen, S., & Perry, E. K. (1992) · Psychological Medicine · doi:10.1017/s0033291700038484 · Cited by 431
Motor blocks in Parkinson's disease
Giladi, N., McMahon, D., Przedborski, S., Flaster, E., Guillory, S., Kostic, V., & Fahn, S. (1992) · Neurology · doi:10.1212/wnl.42.2.333 · Cited by 429
Neurosurgical horizons in Parkinson's disease
Goetz, C. G., De Long, M. R., Penn, R. D., & Bakay, R. A. E. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.1 · Cited by 405
Depression in Parkinson's disease: a quantitative and qualitative analysis.
Gotham, A. M., Brown, R. G., & Marsden, C. D. (1986) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.4.381 · Cited by 388
Self-citationMotor fluctuations in Parkinson's disease: Central pathophysiological mechanisms, part II
Mouradian, M. M., Junecos, J. L., Fabbrini, G., Schlegel, J., Bartko, J. J., & Chase, T. N. (1988) · Annals of Neurology · doi:10.1002/ana.410240304 · Cited by 360
Gastrointestinal dysfunction in Parkinson's disease: Frequency and pathophysiology
Edwards, L. L., Quigley, E. M. M., & Pfeiffer, R. F. (1992) · Neurology · doi:10.1212/wnl.42.4.726 · Cited by 359
Levodopa‐induced dyskinesia: Review, observations, and speculations
Nutt, M. (1990) · Neurology · doi:10.1212/wnl.40.2.340 · Cited by 358
Roller, W. C., Glatt, S., Vetere-Overfield, B., & Hassanein, R. (1989) · Clinical Neuropharmacology · doi:10.1097/00002826-198904000-00003 · Cited by 350
HOW COMMON IS DEMENTIA IN PARKINSON'S DISEASE?
Brown, R. G., & Marsden, C. D. (1984) · The Lancet · doi:10.1016/s0140-6736(84)92807-1 · Cited by 320
Self-citationLesser, R. P., Fahn, S., Snider, S. R., Cote, L. J., Isgreen, W. P., & Barrett, R. E. (1979) · Neurology · doi:10.1212/wnl.29.9_part_1.1253 · Cited by 319
Swallowing abnormalities and their response to treatment in Parkinson's disease
Bushmann, M., Dobmeyer, S. M., Leeker, L., & Perlmutter, J. S. (1989) · Neurology · doi:10.1212/wnl.39.10.1309 · Cited by 318
Diffuse Lewy body disease: clinical features in 15 cases.
Byrne, E. J., Lennox, G., Lowe, J., & Godwin-Austen, R. B. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.6.709 · Cited by 311
Goetz, C. G., Tanner, C. M., Levy, M., Wilson, R. S., & Garron, D. C. (1986) · Movement Disorders · doi:10.1002/mds.870010106 · Cited by 308
Subcutaneous apomorphine in the treatment of Parkinson's disease.
Frankel, J. P., Lees, A. J., Kempster, P. A., & Stern, G. M. (1990) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.2.96 · Cited by 306
Kostic, V., Przedborski, S., Flaster, E., & Sternic, N. (1991) · Neurology · doi:10.1212/wnl.41.2_part_1.202 · Cited by 297
Differential diagnosis between radiation and tumor plexopathy of the pelvis
Thomas, J. E., Cascino, T. L., & Earle, J. D. (1985) · Neurology · doi:10.1212/wnl.35.1.1 · Cited by 294
DEPRENYL IN PARKINSON'S DISEASE
Lees, A. J., Kohout, L. J., Shaw, K. M., Stern, G. M., Elsworth, J. D., Sandler, M., & Youdim, M. B. H. (1977) · The Lancet · doi:10.1016/s0140-6736(77)90725-5 · Cited by 292
Anxiety disorders in patients with Parkinson's disease
(1990) · American Journal of Psychiatry · doi:10.1176/ajp.147.2.217 · Cited by 285
Does long‐term aggravation of Parkinson's disease result from nondopaminergic lesions?
Bonnet, A.-M., Loria, Y., Saint-Hilaire, M.-H., Lhermitte, F., & Agid, Y. (1987) · Neurology · doi:10.1212/wnl.37.9.1539 · Cited by 284
ON-OFF FLUCTUATIONS IN PARKINSON'S DISEASE: A CLINICAL AND NEUROPHARMACOLOGICAL STUDY
HARDIE, R. J., LEES, A. J., & STERN, G. M. (1984) · Brain · doi:10.1093/brain/107.2.487 · Cited by 277
The handicapped and impaired in Great Britain.
Carstairs, V., Harris, A. I., & Buckle, J. (1972) · PubMed · Cited by 274
Parkinson's disease in a Scottish city.
Mutch, W. J., Dingwall-Fordyce, I., Downie, A. W., Paterson, J. G., & Roy, S. K. (1986) · BMJ · doi:10.1136/bmj.292.6519.534 · Cited by 251
Muenter, M. D., & Tyce, G. M. (1971) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)07667-0 · Cited by 248
Levodopa‐induced dyskinesias in Parkinson's disease phenomenology and pathophysiology
Marconi, R., Lefebvre‐Caparros, D., Bonnet, A., Vidailhet, M., Dubois, B., & Agid, Y. (1994) · Movement Disorders · doi:10.1002/mds.870090103 · Cited by 237
Levodopa‐induced dyskinesias in Parkinson's disease: Clinical and pharmacological classification
Luquin, M. R., Scipioni, O., Vaamonde, J., Gershanik, O., & Obeso, J. A. (1992) · Movement Disorders · doi:10.1002/mds.870070204 · Cited by 235
Control of on/off phenomenon by continuous intravenous infusion of levodopa
Quinn, N., Parkes, J. D., & Marsden, C. D. (1984) · Neurology · doi:10.1212/wnl.34.9.1131 · Cited by 232
Self-citationROGERS, D., LEES, A. J., SMITH, E., TRIMBLE, M., & STERN, G. M. (1987) · Brain · doi:10.1093/brain/110.3.761 · Cited by 218
Quinn, N. P., Lang, A. E., Koller, W. C., & Marsden, C. D. (1986) · The Lancet · doi:10.1016/s0140-6736(86)91674-0 · Cited by 217
Self-citationHughes, A. J., Bishop, S., Kleedorfer, B., Turjanski, N., Fernandez, W., Lees, A. J., & Stern, G. M. (1993) · Movement Disorders · doi:10.1002/mds.870080208 · Cited by 204
Depression and disability in Parkinson's disease: a follow-up of 132 cases
Brown, R. G., Maccarthy, B., Gotham, A.-M., Der, G. J., & Marsden, C. D. (1988) · Psychological Medicine · doi:10.1017/s0033291700001872 · Cited by 194
Self-citationMood changes and “on‐off” phenomena in Parkinson's disease
Menza, M. A., Sage, J., Marshall, E., Cody, R., & Duvoisin, R. (1990) · Movement Disorders · doi:10.1002/mds.870050210 · Cited by 174
Speech therapy for Parkinson's disease.
Scott, S., & Caird, F. I. (1983) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.46.2.140 · Cited by 174
Levodopa pharmacokinetic mechanisms and motor fluctuations in Parkinson's disease
Fabbrini, G., Juncos, J., Mouradian, M. M., Serrati, C., & Chase, T. N. (1987) · Annals of Neurology · doi:10.1002/ana.410210409 · Cited by 174
Fox, M. W., Ahlskog, J. E., & Kelly, P. J. (1991) · Journal of Neurosurgery · doi:10.3171/jns.1991.75.5.0723 · Cited by 172
Antemortem diagnosis of diffuse Lewy body disease
Crystal, H. A., Dickson, D. W., Lizardi, J. E., Davies, P., & Wolfson, L. I. (1990) · Neurology · doi:10.1212/wnl.40.10.1523 · Cited by 170
Early combination of bromocriptine and levodopa in the treatment of Parkinson's disease
Rinne, U. K. (1987) · Neurology · doi:10.1212/wnl.37.5.826 · Cited by 166
The Impact of Treatment with Levodopa on Parkinson's Disease
(1980) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a067623 · Cited by 164
Sustained bromocriptine therapy in previously untreated patients with Parkinson's disease.
Lees, A. J., & Stern, G. M. (1981) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.44.11.1020 · Cited by 163
Low‐dose L‐dopa therapy in Parkinson's disease: A 6‐year follow‐up study
Poewe, W. H., Lees, A. J., & Stern, G. M. (1986) · Neurology · doi:10.1212/wnl.36.11.1528 · Cited by 163
On‐off phenomenon: Relation to levodopa pharmacokinetics and pharmacodynamics
Nutt, J. G. (1987) · Annals of Neurology · doi:10.1002/ana.410220415 · Cited by 159
Anal Sphincter Dysfunction in Parkinson's Disease
Mathers, S. E., Kempster, P. A., Law, P. J., Frankel, J. P., Bartram, C. I., Lees, A. J., Stern, G. M., & Swash, M. (1989) · Archives of Neurology · doi:10.1001/archneur.1989.00520460037010 · Cited by 158
Exercise therapy for Parkinson's disease
Palmer, S. S., Mortimer, J. A., Webster, D. D., Bistevins, R., & Dickinson, G. L. (1986) · Archives of Physical Medicine and Rehabilitation · doi:10.1016/0003-9993(86)90007-9 · Cited by 158
Continuous and intermittent levodopa differentially affect basal ganglia function
Juncos, J. L., Engber, T. M., Raisman, R., Susel, Z., Thibaur, F., Ploska, A., Agid, Y., & Chase, T. N. (1989) · Annals of Neurology · doi:10.1002/ana.410250509 · Cited by 158
The spectrum of levodopa‐related fluctuations in Parkinson's disease
Riley, D. E., & Lang, A. E. (1993) · Neurology · doi:10.1212/wnl.43.8.1459 · Cited by 155
Increase of Parkinson disability after fluoxetine medication
Steur, E. N. H. J. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.211 · Cited by 155
Speech disorders of Parkinsonism: a review.
Critchley, E. M. R. (1981) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.44.9.751 · Cited by 154
Clozapine in the treatment of parkinsonian patients with dopaminomimetic psychosis
Wolters, E. C., Hurwitz, T. A., Mak, E., Teal, P. A., Peppard, F. R., Remick, R. A., Calne, S. M., & Calne, D. B. (1990) · Neurology · doi:10.1212/wnl.40.5.832 · Cited by 153
Rationale for continuous dopaminomimetic therapy of Parkinson's disease.
Chase, T. N., Baronti, F., Fabbrini, G., Heuser, I. J. E., Juncos, J. L., & Mouradian, M. M. (1989) · PubMed · Cited by 152
Clozapine in the treatment of psychosis in Parkinson's disease
Friedman, J. H., & Lannon, M. C. (1989) · Neurology · doi:10.1212/wnl.39.9.1219 · Cited by 147
Mood swings associated with the ‘on—off’ phenomenon in Parkinson's disease
Nissenbaum, H., Quinn, N. P., Brown, R. G., Toone, B., Gotham, A.-M., & MARSDEN, C. D. (1987) · Psychological Medicine · doi:10.1017/s0033291700000702 · Cited by 141
Self-citationBrown, R. G., Marsden, C. D., Quinn, N., & Wyke, M. A. (1984) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.47.5.454 · Cited by 140
Self-citationWeiner, W. J., Factor, S. A., Sanchez‐Ramos, J., Singer, C., Sheldon, C., Cornelius, L., & Ingenito, A. (1993) · Neurology · doi:10.1212/wnl.43.1_part_1.21 · Cited by 137
Confusion, dementia and anticholinergics in Parkinson's disease.
de Smet, Y., Ruberg, M., Serdaru, M., Dubois, B., Lhermitte, F., & Agid, Y. (1982) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.45.12.1161 · Cited by 133
Treatment of drug-induced exogenous psychosis in Parkinsonism with clozapine and fluperlapine
Scholz, E., & DICHGANS, J. (1985) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf00380972 · Cited by 128
Lisuride, a dopamine agonist in the treatment of early Parkinson's disease
Rinne, U. K. (1989) · Neurology · doi:10.1212/wnl.39.3.336 · Cited by 127
Akathisia in idiopahic Parkinson's disease
Lang, A. E., & Johnson, K. (1987) · Neurology · doi:10.1212/wnl.37.3.477 · Cited by 122
Long‐term duodenal infusion of levodopa for motor fluctuations in parkinsonism
Sage, J. I., Trooskin, S. Z., Sonsalla, P. K., Heikkila, R. E., & Duvoisin, R. C. (1988) · Annals of Neurology · doi:10.1002/ana.410240116 · Cited by 120
Robertson, S. J., & Thomson, F. (1984) · International Journal of Language & Communication Disorders · doi:10.3109/13682828409029837 · Cited by 113
Combined bromocriptine‐levodopa therapy early in Parkinson's disease
Rinne, U. K. (1985) · Neurology · doi:10.1212/wnl.35.8.1196 · Cited by 109
Micturition Disturbance in Parkinson's Disease
FITZMAURICE, H., Fowler, C. J., Rickards, D., Kirby, R. S., Quinn, N. P., MARSDEN, C. D., Milroy, E. J. G., & Turner-Warwick, R. T. (1985) · British Journal of Urology · doi:10.1111/j.1464-410x.1985.tb07025.x · Cited by 104
Self-citationDoes levodopa aggravate Parkinson's disease?
Blin, J., Bonnet, A.-M., & Agid, Y. (1988) · Neurology · doi:10.1212/wnl.38.9.1410 · Cited by 103
Comparison of pergolide and bromocriptine therapy in parkinsonism
LeWitt, P. A., Ward, C. D., Larsen, T., Raphaelson, M. I., Newman, R. P., Foster, N. L., Dambrosia, J. M., & Calne, D. B. (1983) · Neurology · doi:10.1212/wnl.33.8.1009 · Cited by 101
The clinical physiology of side effects in long-term L-DOPA therapy.
Barbeau, A. (1974) · PubMed · Cited by 97
Episodic unresponsiveness to single doses of L‐dopa in parkinsonian fluctuators
Melamed, E., Bitton, V., & Zelig, O. (1986) · Neurology · doi:10.1212/wnl.36.1.100 · Cited by 91
Onset and End-of-Dose Levodopa-Induced Dyskinesias
Lhermitte, F. (1978) · Archives of Neurology · doi:10.1001/archneur.1978.00500290007002 · Cited by 91
Mood changes associated with "end-of-dose deterioration" in Parkinson's disease: a controlled study.
Cantello, R. M., Gilli, M., Riccio, A., & Bergamasco, B. (1986) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.49.10.1182 · Cited by 88
Severity of Parkinson's disease is a risk factor for peak-dose dyskinesia.
Horstink, M. W. I. M., Zijlmans, J. C. M., Pasman, J. W., et al. (1990) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.53.3.224 · Cited by 76
PET studies on the early and differential diagnosis of Parkinson's disease.
Brooks, D. J. (1993) · PubMed · Cited by 70
Oral levodopa/carbidopa solution versus tablets in Parkinson's patients with severe fluctuations
Kurth, M., Tetrad, J. W., Irwin, I., Lyness, W. H., & Langston, J. W. (1993) · Neurology · doi:10.1212/wnl.43.5.1036 · Cited by 68
Poewe, W., Lees, A. J., & Stern, G. M. (1986) · Clinical Neuropharmacology · doi:10.1097/00002826-198610000-00003 · Cited by 62
Interaction of levodopa and metoclopramide on gastric emptying
Berkowitz, D. M., & McCallum, R. W. (1980) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1980.55 · Cited by 58
Protein redistribution diet restores motor function in patients with dopa‐resistant “off” periods
Pincus, J. H., & Barry, K. (1988) · Neurology · doi:10.1212/wnl.38.3.481 · Cited by 56
Epidemiology of some neurological diseases with special reference to work load on the NHS
Wade, D. T., & Hewer, R. L. (1986) · International Rehabilitation Medicine · doi:10.3109/03790798709166197 · Cited by 56
EFFECT OF L-DOPA ON COURSE OF PARKINSON'S DISEASE
Curtis, L. D., Lees, A. J., Stern, G. M., & Marmot, M. G. (1984) · The Lancet · doi:10.1016/s0140-6736(84)90493-8 · Cited by 54
Mortality from Parkinson's disease in England and Wales 1921-89.
Clarke, C. E. (1993) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.56.6.690 · Cited by 46
Continuous levodopa infusions to treat complex dystonia in Parkinson's disease
Sage, J. I., McHale, D. M., Sonsalla, P. K., Vitagliano, D., & Heikkila, R. E. (1989) · Neurology · doi:10.1212/wnl.39.7.888 · Cited by 42
Early combination therapy with bromocriptine and levodopa in parkinson's disease
Factor, S. A., & Weiner, W. J. (1993) · Movement Disorders · doi:10.1002/mds.870080302 · Cited by 42
Multicenter controlled study of Sinemet CR vs Sinemet (25/100) in advanced Parkinson's disease.
Hutton, J. T., Morris, J. L., Bush, D., Smith, M., Liss, C. L., & Reines, S. A. (1989) · PubMed · Cited by 36
Response fluctuations in Parkinson's disease
Roos, R. A. C., VREDEVOOGD, C. B., & van der Velde, E. A. (1990) · Neurology · doi:10.1212/wnl.40.9.1344 · Cited by 35
Long-acting carbidopa-levodopa in the management of moderate and advanced Parkinson's disease.
Hutton, J. T., & Morris, J. L. (1992) · PubMed · Cited by 27
The occupational therapist and the patient with Parkinson's disease.
Beattie, A., & Caird, F. I. (1980) · BMJ · doi:10.1136/bmj.280.6228.1354 · Cited by 25
Which risk factors predict the levodopa response in fluctuating Parkinson's disease?
Horstink, M. W. I. M., Zijlmans, J. C. M., Pasman, J. W., Berger, H. J. C., Korten, J. J., & Hof, M. A. V. ’. (1990) · Annals of Neurology · doi:10.1002/ana.410270514 · Cited by 25
Goetz, C. G., Tanner, C. M., Gilley, D. W., & Klawans, H. L. (1989) · PubMed · Cited by 17
Off‐period screaming accompanying motor fluctuations in Parkinson's disease
Steiger, M. J., Quinn, N. P., Toone, B., & MARSDEN, C. D. (1991) · Movement Disorders · doi:10.1002/mds.870060120 · Cited by 13
Self-citation
Cited by
Hausdorff, J. M., Cudkowicz, M. E., Firtion, R., Wei, J. Y., & Goldberger, A. L. (1998) · Movement Disorders · doi:10.1002/mds.870130310 · Cited by 903
The role of the basal ganglia in nociception and pain
Chudler, E. H., & Dong, W. K. (1995) · Pain · doi:10.1016/0304-3959(94)00172-b · Cited by 599
Movement Disorders in People With Parkinson Disease: A Model for Physical Therapy
Morris, M. E. (2000) · Physical Therapy · doi:10.1093/ptj/80.6.578 · Cited by 553
Clinical Approach to Parkinson's Disease: Features, Diagnosis, and Principles of Management
Massano, J., & Bhatia, K. P. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a008870 · Cited by 422
Pacchetti, C., Mancini, F., Aglieri, R., Fundarò, C., Martignoni, E., & Nappi, G. (2000) · Psychosomatic Medicine · doi:10.1097/00006842-200005000-00012 · Cited by 420
Metadata
- Authors
- Marsden, C. D.
- Venue
- Journal of Neurology, Neurosurgery & Psychiatry
- Publisher
- BMJ
- Published
- 1994-06-01
- Volume
- 57
- Issue
- 6
- Pages
- 672-681
- ISSN
- 0022-3050 (ISSN-L)
- OpenAlex
- W4210995338
- Cited by
- 365
- References
- 101
- FWCI
- 9.36
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.